Alan Chalmers reports that progress was made at a conference on the Council of Europe’s proposed MEDICRIME convention, despite the controversy surrounding the World Health Organization’s IMPACT initiative.
The latest events in the battle against counterfeiting (or falsification) of drugs and medical devices have left countries divided on how best to move forward...
Please login to read the full article.